Log in
Enquire now

List of Orexigen Therapeutics patents

List of Orexigen Therapeutics patents
List of GRIFFIN ANALYTICAL TECHNOLOGIES, INC. patents
List of A&G Pharmaceutical, Inc. patents
List of Ryobi patents
List of companies in Berggruen Holdings's investment portfolio
List of SBIR/STTR awards granted to Veloxiti, Inc.
Patents where
Current Assignee
Name
is
Orexigen TherapeuticsOrexigen Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 8088786 Layered pharmaceutical formulations

Patent 8088786 was granted and assigned to Orexigen Therapeutics on January, 2012 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8088786
January 3, 2012
‌
US Patent 7462626 Compositions for affecting weight loss

Patent 7462626 was granted and assigned to Orexigen Therapeutics on December, 2008 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7462626
December 9, 2008
‌
US Patent 8969371 Compositions and methods for weight loss in at risk patient populations

Patent 8969371 was granted and assigned to Orexigen Therapeutics on March, 2015 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8969371
March 3, 2015
‌
US Patent 9801875 Compositions and methods for weight loss in at risk patient populations

Patent 9801875 was granted and assigned to Orexigen Therapeutics on October, 2017 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9801875
October 31, 2017
‌
US Patent 8916195 Sustained release formulation of naltrexone

Patent 8916195 was granted and assigned to Orexigen Therapeutics on December, 2014 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8916195
December 23, 2014
‌
US Patent 8722085 Methods for administering weight loss medications

Patent 8722085 was granted and assigned to Orexigen Therapeutics on May, 2014 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8722085
May 13, 2014
‌
US Patent 9457005 Compositions and methods for increasing insulin sensitivity

Patent 9457005 was granted and assigned to Orexigen Therapeutics on October, 2016 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9457005
October 4, 2016
‌
US Patent 9633575 Methods of treating overweight and obesity

Patent 9633575 was granted and assigned to Orexigen Therapeutics on April, 2017 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9633575
April 25, 2017
‌
US Patent 9248123 Methods of providing weight loss therapy in patients with major depression

Patent 9248123 was granted and assigned to Orexigen Therapeutics on February, 2016 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9248123
February 2, 2016
‌
US Patent 9107837 Sustained release formulation of naltrexone

Patent 9107837 was granted and assigned to Orexigen Therapeutics on August, 2015 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9107837
August 18, 2015
‌
US Patent 9119850 Compositions and methods for weight loss in at risk patient populations

Patent 9119850 was granted and assigned to Orexigen Therapeutics on September, 2015 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9119850
September 1, 2015
‌
US Patent 9125868 Methods for administering weight loss medications

Patent 9125868 was granted and assigned to Orexigen Therapeutics on September, 2015 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9125868
September 8, 2015
‌
US Patent 7425571 Method for treating obesity

Patent 7425571 was granted and assigned to Orexigen Therapeutics on September, 2008 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7425571
September 16, 2008
‌
US Patent 7375111 Compositions for affecting weight loss

Patent 7375111 was granted and assigned to Orexigen Therapeutics on May, 2008 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7375111
May 20, 2008
‌
US Patent 8815889 Compositions and methods for increasing insulin sensitivity

Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8815889
August 26, 2014
‌
US Patent 8318788 Layered pharmaceutical formulations

Patent 8318788 was granted and assigned to Orexigen Therapeutics on November, 2012 by the United States Patent and Trademark Office.

Orexigen Therapeutics
Orexigen Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8318788
November 27, 2012
16 results
0 selected
16 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us